vs

Side-by-side financial comparison of CAMDEN NATIONAL CORP (CAC) and Inogen Inc (INGN). Click either name above to swap in a different company.

Inogen Inc is the larger business by last-quarter revenue ($68.6M vs $64.3M, roughly 1.1× CAMDEN NATIONAL CORP). Over the past eight quarters, CAMDEN NATIONAL CORP's revenue compounded faster (22.6% CAGR vs 4.2%).

Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

CAC vs INGN — Head-to-Head

Bigger by revenue
INGN
INGN
1.1× larger
INGN
$68.6M
$64.3M
CAC
Faster 2-yr revenue CAGR
CAC
CAC
Annualised
CAC
22.6%
4.2%
INGN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CAC
CAC
INGN
INGN
Revenue
$64.3M
$68.6M
Net Profit
$21.9M
Gross Margin
51.4%
Operating Margin
-13.6%
Net Margin
34.0%
Revenue YoY
3.4%
Net Profit YoY
EPS (diluted)
$1.29
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAC
CAC
INGN
INGN
Q1 26
$64.3M
Q4 25
$68.1M
$68.6M
Q3 25
$65.4M
$79.1M
Q2 25
$62.3M
$79.2M
Q1 25
$60.1M
$68.5M
Q4 24
$47.6M
$66.3M
Q3 24
$45.0M
$74.9M
Q2 24
$42.8M
$74.4M
Net Profit
CAC
CAC
INGN
INGN
Q1 26
$21.9M
Q4 25
$22.6M
Q3 25
$21.2M
$-5.3M
Q2 25
$14.1M
$-4.2M
Q1 25
$7.3M
$-6.2M
Q4 24
$14.7M
Q3 24
$13.1M
$-6.0M
Q2 24
$12.0M
$-5.6M
Gross Margin
CAC
CAC
INGN
INGN
Q1 26
Q4 25
51.4%
Q3 25
52.2%
Q2 25
52.2%
Q1 25
53.1%
Q4 24
54.7%
Q3 24
55.2%
Q2 24
57.4%
Operating Margin
CAC
CAC
INGN
INGN
Q1 26
Q4 25
41.5%
-13.6%
Q3 25
40.5%
-9.0%
Q2 25
28.5%
-7.7%
Q1 25
10.3%
-11.2%
Q4 24
38.7%
-17.2%
Q3 24
35.2%
-10.4%
Q2 24
34.7%
-9.5%
Net Margin
CAC
CAC
INGN
INGN
Q1 26
34.0%
Q4 25
33.1%
Q3 25
32.4%
-6.7%
Q2 25
22.6%
-5.2%
Q1 25
12.2%
-9.0%
Q4 24
30.8%
Q3 24
29.1%
-8.0%
Q2 24
28.0%
-7.5%
EPS (diluted)
CAC
CAC
INGN
INGN
Q1 26
$1.29
Q4 25
$1.33
$-0.26
Q3 25
$1.25
$-0.20
Q2 25
$0.83
$-0.15
Q1 25
$0.43
$-0.25
Q4 24
$1.00
$-0.41
Q3 24
$0.90
$-0.25
Q2 24
$0.81
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAC
CAC
INGN
INGN
Cash + ST InvestmentsLiquidity on hand
$103.7M
Total DebtLower is stronger
$514.4M
Stockholders' EquityBook value
$710.0M
$192.2M
Total Assets
$7.0B
$298.6M
Debt / EquityLower = less leverage
0.72×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAC
CAC
INGN
INGN
Q1 26
Q4 25
$103.7M
Q3 25
$106.5M
Q2 25
$103.7M
Q1 25
$118.9M
Q4 24
$113.8M
Q3 24
$105.7M
Q2 24
$97.9M
Total Debt
CAC
CAC
INGN
INGN
Q1 26
$514.4M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CAC
CAC
INGN
INGN
Q1 26
$710.0M
Q4 25
$696.6M
$192.2M
Q3 25
$676.4M
$197.2M
Q2 25
$652.1M
$199.5M
Q1 25
$640.1M
$198.0M
Q4 24
$531.2M
$173.9M
Q3 24
$529.9M
$185.4M
Q2 24
$508.3M
$187.6M
Total Assets
CAC
CAC
INGN
INGN
Q1 26
$7.0B
Q4 25
$7.0B
$298.6M
Q3 25
$7.0B
$307.0M
Q2 25
$6.9B
$312.0M
Q1 25
$7.0B
$308.4M
Q4 24
$5.8B
$296.2M
Q3 24
$5.7B
$306.2M
Q2 24
$5.7B
$308.9M
Debt / Equity
CAC
CAC
INGN
INGN
Q1 26
0.72×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAC
CAC
INGN
INGN
Operating Cash FlowLast quarter
$-943.0K
Free Cash FlowOCF − Capex
$-1.9M
FCF MarginFCF / Revenue
-2.8%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAC
CAC
INGN
INGN
Q1 26
Q4 25
$63.9M
$-943.0K
Q3 25
$36.1M
$2.2M
Q2 25
$6.0M
$4.3M
Q1 25
$1.0M
$-16.8M
Q4 24
$60.9M
$-3.0M
Q3 24
$-14.5M
$7.0M
Q2 24
$14.5M
$6.7M
Free Cash Flow
CAC
CAC
INGN
INGN
Q1 26
Q4 25
$58.2M
$-1.9M
Q3 25
$35.4M
$1.6M
Q2 25
$4.5M
$3.7M
Q1 25
$-727.0K
$-17.1M
Q4 24
$55.4M
$-3.3M
Q3 24
$-16.2M
$5.3M
Q2 24
$13.2M
$6.6M
FCF Margin
CAC
CAC
INGN
INGN
Q1 26
Q4 25
85.5%
-2.8%
Q3 25
54.1%
2.0%
Q2 25
7.3%
4.6%
Q1 25
-1.2%
-24.9%
Q4 24
116.4%
-5.0%
Q3 24
-36.0%
7.1%
Q2 24
30.8%
8.9%
Capex Intensity
CAC
CAC
INGN
INGN
Q1 26
Q4 25
8.4%
1.4%
Q3 25
1.1%
0.7%
Q2 25
2.4%
0.9%
Q1 25
2.9%
0.4%
Q4 24
11.7%
0.5%
Q3 24
3.8%
2.2%
Q2 24
3.0%
0.1%
Cash Conversion
CAC
CAC
INGN
INGN
Q1 26
Q4 25
2.83×
Q3 25
1.70×
Q2 25
0.43×
Q1 25
0.14×
Q4 24
4.15×
Q3 24
-1.11×
Q2 24
1.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CAC
CAC

Net Interest Income$52.4M81%
Noninterest Income$12.0M19%

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

Related Comparisons